Healthcare Services

Rising demand for biopharmaceuticals is driving growth in the bioreactors market

April 17, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Bioreactors Market Projected To Reach By 2030?

The bioreactors market has experienced rapid expansion in recent years. It is projected to increase from $10.61 billion in 2025 to $12.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. The historical growth of this market can be attributed to factors such as the expansion of biologics production, an increase in fermentation-based manufacturing, the rising adoption of fed-batch processes, growing investment in biopharma R&D, and the availability of advanced bioprocess control systems.

The bioreactors market is projected to experience substantial expansion in the coming years, reaching a valuation of $21.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.6%. This anticipated growth during the forecast period is fueled by several factors, including a heightened demand for high-yield bioprocessing, the ongoing expansion of personalized medicine manufacturing, the growing incorporation of AI-driven process optimization, an intensified emphasis on production efficiency, and the wider uptake of continuous manufacturing models. Key trends anticipated within this period involve the increasing embrace of automated bioreactor systems, the expanding utilization of continuous bioprocessing technologies, an escalating requirement for scalable bioreactor platforms, the broadening availability of single-use bioreactor solutions, and a heightened emphasis on process monitoring and control.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/bioreactors-global-market-report

What Leading Drivers Are Supporting The Bioreactors Market Expansion?

The bioreactors market is expected to experience growth driven by the increasing need for biopharmaceuticals in the coming period. Biopharmaceuticals are medical products sourced from biological entities such as proteins, cells, and living organisms, utilized to prevent, treat, or manage various diseases. This rising demand for biopharmaceuticals is attributed to advancements in medical research, the progression of personalized medicine, and the necessity for innovative treatments, leading to improved healthcare outcomes globally. Bioreactors are essential for biopharmaceuticals as they enable efficient and scalable production of therapeutic products, ensuring consistent quality, reducing production costs, and aiding in the development of innovative and life-enhancing medicines. For instance, in November 2025, the Organisation for Economic Co operation and Development, a France-based intergovernmental economic organization, reported that per capita expenditure on retail pharmaceuticals averaged USD 766 (adjusted for differences in purchasing power) in OECD countries in 2023. Therefore, the increasing demand for biopharmaceuticals is propelling growth in the bioreactors market.

What Are The Key Segment Divisions In The Bioreactors Market Segment Structure?

The bioreactors market covered in this report is segmented –

1) By Type Of Bioprocess: Batch And Fed-Batch, Continuous

2) By Cell: Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells

3) By Control: Manual, Automated

4) By Usage: Lab Scale Production, Pilot Scale Production, Full Scale Production

5) By End-Use: Research And Development (R&D) Organizations, Biopharmaceutical (Biopharma) Manufacturers, Contract Manufacturing Organizations (CMOS)

Subsegments:

1) By Batch And Fed-Batch: Traditional Batch Bioreactors, Fed-Batch Bioreactors

2) By Continuous: Perfusion Bioreactors, Continuous Stirred Tank Bioreactors (CSTR)

What Emerging Trends Are Seen In The Bioreactors Market?

Major companies operating in the bioreactors market are concentrating on creating advanced products, such as fixed-bed bioreactors, to facilitate the cultivation of more complex biological cultures. A fixed-bed bioreactor is characterized by biological organisms being affixed to a solid support, typically composed of porous materials like beads, fibers, or granules. This design leads to improved mass transfer, minimized shear stress, and enhanced control over biological processes. For instance, in October 2024, Univercells Technologies, a biotechnology company based in Belgium, launched the Scale-X Nexo bioreactor. This innovative bioreactor, which boasts a 0.5 m² growth surface, is specifically engineered to optimize cell culture process development, delivering significant advantages for biopharmaceutical companies and research institutions. The Scale-X Nexo enables seamless scalability to larger models, reduces media and reagent consumption, and can lower operational costs by up to 60% compared to traditional entry-level bioreactors. Additionally, its integration with the Skaia Vision application software further boosts productivity by providing precise cell count estimations without the need for direct sampling.

Which Organizations Are Engaged In The Bioreactors Market?

Major companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, PBS Biotech Inc., TAP Biosystems, BBI-Biotech GmbH, HiTec Zang GmbH, Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, Shanghai Ritai Medicine Equipment Project Co. Ltd.

Get The Full Bioreactors Market Report:

https://www.thebusinessresearchcompany.com/report/bioreactors-global-market-report

Which Geographic Region Dominates The Bioreactors Market?

North America was the largest region in the bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Bioreactors Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/bioreactors-global-market-report

Browse Through More Reports Similar to the Global Bioreactors Market 2026, By The Business Research Company

Membrane Bioreactor Market Report 2026

https://www.thebusinessresearchcompany.com/report/membrane-bioreactor-global-market-report

Bioreactors And Fermenters Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioreactors-and-fermenters-global-market-report

Airlift Bioreactors Market Report 2026

https://www.thebusinessresearchcompany.com/report/airlift-bioreactors-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795